Drugs / 5- fluorine pyrimidine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03982680 | Jul 2019 → May 2021 | cholangiocarcinoma | Jiangmen Central Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5- fluorine pyrimidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03982680 ↗ |